PURPOSE: To investigate which factors are related to patient reported cosmetic outcome (PRCO) after breast conserving therapy. METHODS: From 2004 to 2011, 2421 cT1-2N0-2a breast cancer patients were randomised in the Young Boost Trial between a 16 and a 26Gy boost to the tumour bed. Cosmesis was scored subjectively by the patient and physician, and objectively using BCCT.core, at baseline, one and four years after treatment. Presence of fibrosis, QoL and rib pain at four years were also scored. Data were complete for 864 patients. The relation between the separate components was investigated using a proportional odds model. RESULTS: Of the 7 BCCT.core parameters, the distance from nipple to inframammary fold and the length of the breast con...
Purpose: In the Young Boost trial (YBT), breast cancer patientsMethods: From 2004 to 2011, 2421 cT1-...
Purpose: In the Young Boost trial (YBT), breast cancer patients Methods: From 2004 to 2011, 2421 cT1...
Abstract: Aim: In early breast cancer treated with breast conserving therapy (BCT) the cosmetic effe...
Purpose: To investigate which factors are related to patient reported cosmetic outcome (PRCO) after ...
Purpose: To investigate which factors are related to patient reported cosmetic outcome (PRCO) after ...
Purpose: To investigate which factors are related to patient reported cosmetic outcome (PRCO) after ...
Purpose: To investigate which factors are related to patient reported cosmetic outcome (PRCO) after ...
Purpose: To investigate which factors are related to patient reported cosmetic outcome (PRCO) after ...
Purpose: To investigate which factors are related to patient reported cosmetic outcome (PRCO) after ...
Item does not contain fulltextPURPOSE: To investigate which factors are related to patient reported ...
Purpose: In the Young Boost trial (YBT), breast cancer patientsMethods: From 2004 to 2011, 2421 cT1-...
Purpose: In the Young Boost trial (YBT), breast cancer patientsMethods: From 2004 to 2011, 2421 cT1-...
Purpose: In the Young Boost trial (YBT), breast cancer patientsMethods: From 2004 to 2011, 2421 cT1-...
Purpose: In the Young Boost trial (YBT), breast cancer patientsMethods: From 2004 to 2011, 2421 cT1-...
Purpose: In the Young Boost trial (YBT), breast cancer patientsMethods: From 2004 to 2011, 2421 cT1-...
Purpose: In the Young Boost trial (YBT), breast cancer patientsMethods: From 2004 to 2011, 2421 cT1-...
Purpose: In the Young Boost trial (YBT), breast cancer patients Methods: From 2004 to 2011, 2421 cT1...
Abstract: Aim: In early breast cancer treated with breast conserving therapy (BCT) the cosmetic effe...
Purpose: To investigate which factors are related to patient reported cosmetic outcome (PRCO) after ...
Purpose: To investigate which factors are related to patient reported cosmetic outcome (PRCO) after ...
Purpose: To investigate which factors are related to patient reported cosmetic outcome (PRCO) after ...
Purpose: To investigate which factors are related to patient reported cosmetic outcome (PRCO) after ...
Purpose: To investigate which factors are related to patient reported cosmetic outcome (PRCO) after ...
Purpose: To investigate which factors are related to patient reported cosmetic outcome (PRCO) after ...
Item does not contain fulltextPURPOSE: To investigate which factors are related to patient reported ...
Purpose: In the Young Boost trial (YBT), breast cancer patientsMethods: From 2004 to 2011, 2421 cT1-...
Purpose: In the Young Boost trial (YBT), breast cancer patientsMethods: From 2004 to 2011, 2421 cT1-...
Purpose: In the Young Boost trial (YBT), breast cancer patientsMethods: From 2004 to 2011, 2421 cT1-...
Purpose: In the Young Boost trial (YBT), breast cancer patientsMethods: From 2004 to 2011, 2421 cT1-...
Purpose: In the Young Boost trial (YBT), breast cancer patientsMethods: From 2004 to 2011, 2421 cT1-...
Purpose: In the Young Boost trial (YBT), breast cancer patientsMethods: From 2004 to 2011, 2421 cT1-...
Purpose: In the Young Boost trial (YBT), breast cancer patients Methods: From 2004 to 2011, 2421 cT1...
Abstract: Aim: In early breast cancer treated with breast conserving therapy (BCT) the cosmetic effe...